Alinity reagent
Ended Awarded
- Contract number
- HT009025FG0530025
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $25,000
Award facts
- Contract value 100% obligated
- $24,999.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- North Chicago, IL 60064, USA
Award details come from SAM.gov/FPDS.
About this award
Abbott Laboratories Inc., through its Abbott Diagnostics Division, was awarded a Blanket Purchase Agreement (BPA) call contract on May 30, 2025, for the supply of Alinity reagent to the Defense Health Agency. This firm fixed-price contract, valued at $24,999.99, represents a child order under a larger BPA vehicle and carries no set-aside designation, indicating full and open competition. The contract will be performed at Abbott's facility in North Chicago, Illinois, with an ultimate completion date of September 30, 2025. The Defense Health Agency, operating under the Department of Defense, procures medical diagnostic equipment and supplies to support military medical treatment facilities and healthcare operations across the federal defense sector.
Alinity reagents are consumable products used with Abbott's automated clinical chemistry and immunoassay analyzers to perform diagnostic testing. This award reflects Abbott Laboratories' established role as a critical supplier of medical diagnostic technologies and laboratory solutions to federal healthcare agencies. The company maintains a substantial portfolio of BPA contracts with the Defense Health Agency and Veterans Affairs for similar clinical laboratory equipment and supplies, typically structured as indefinite delivery vehicles that enable streamlined procurement of diagnostic products. The relatively modest ceiling value of this particular call order is consistent with task order issuance patterns under larger master agreement vehicles that support ongoing federal healthcare laboratory operations.
Quick answers
Who was awarded contract HT009025FG0530025?
HT009025FG0530025 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on May 30, 2025.
How much is contract HT009025FG0530025 worth?
The government has obligated $25,000 on HT009025FG0530025.
Is contract HT009025FG0530025 an order under another contract?
Yes. HT009025FG0530025 is a BPA call under FA301624A0044, a blanket purchase agreement.
Was contract HT009025FG0530025 competed?
The extent of competition for HT009025FG0530025 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award